LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company specializing in oncology, today announced that President and Chief Executive Officer Steven A. Kriegsman and Vice President of Business Development David J. Haen will present a business update at the Roth Capital Partners 24th Annual OC Growth Stock Conference on Monday, March 12 at 12:30 p.m. Pacific time (3:30 p.m. Eastern time). The conference is being held at the Ritz-Carlton in Dana Point, Calif.
